In a new study, co-authored by Peterhouse Research Fellow, Dr Thomas Michaels, a team of researchers at Harvard University developed a model to better understand how drugs inhibit the growth of protein fibrils, offering a guide to develop more effective strategies to target protein aggregation diseases. The researchers found that different drugs target different stages of protein aggregation and the timing of their administration plays a critical role in inhibiting fibril growth. The study was published in Proceedings of the National Academy of Sciences USA.

Read more about the findings here:  https://www.seas.harvard.edu/news/2019/08/using-math-to-help-treat-alzheimer-s-parkinson-s-and-other-diseases